Navigation Links
Trevena, Inc. Announces $24 Million Series A Financing
Date:3/5/2008

nd more than 230 have been acquired. For additional information, visit http://www.nea.com

About Polaris Venture Partners

Polaris Venture Partners is a partnership of experienced venture capital investors and technology executives. Our mission is to identify and invest in seed, first round, and early stage information technology and life science businesses with exceptional promise and help them grow into sustainable, market-leading companies. In addition, Polaris is committed to providing growth equity and shareholder liquidity to established companies in the technology, healthcare, manufacturing, media, communications, and business services sectors. The firm has over $3 billion under management and current investments in more than 100 companies. For information on Polaris Venture Partners, visit http://www.polarisventures.com


'/>"/>
SOURCE Trevena, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , SILVER SPRING, Md., Nov. 30 /PRNewsw...se consumers a bronzed body year-round, but the ul...serious health risks. ,, (Logo: http://www.ne...Although some people think that a tan gives them a..." says Sharon Miller, M.S.E.E., a Food and Drug Ad...
(Date:11/30/2009)... , CHICAGO, Nov. 30 Physicians...reported today on results of a study demonstrating...CT angiography (cCTA) by Rcadia,s COR Analyzer Sys... artery stenosis in hospital emergency department ... automated system to enhance the use of cCTA has p...
(Date:11/30/2009)... University of Navarra Hospital has launched a ser...cacy of an immunotherapy treatment. This approach ...produced from healthy and tumour cells from the pa...astomas, one of the most aggressive and frequent m...to participating patients combined with the standa...
(Date:11/30/2009)... Peter J. Rappa, MD, explores ...body in his new book "Healing Heart to Soul: ... Life" (Brown Books 2009). , ...Experiencing and refusing to let go of negative em...s, can weigh heavy on our shoulders. Oftentimes, t...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Re...h report is available in its catalogue: ,, Gen...rtunities ,, http://www.reportlinker.com/p016...pportunities.html ,, Gene therapy promises to...e. Although no significant achievements for curing...
Breaking Medicine News(10 mins):Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5
...nts , , MONDAY, Jan. 7 (HealthDay News) --...sunlight, some foods and supplements -- are assoc...blems such as heart attack and stroke, U.S. resear...sachusetts city. , The research team found that th...
...r Integrative Health Solutions for Te...Jan. 7 Gaiam, Inc., the,leading distributor of sp...nt of the fitness and wellness market, today annou... - obesity,type 2 diabetes, back pain, high blood ...
...ga AB, a subsidiary of Cambrex Corporation (NYSE: ... a purchase agreement for all of the stock,of ProS...ingredients,("API") research and development compa... a spin off from Tallinn University,of Technology,...
...r prescriptions, kept exam dates, study finds , ...buying contact lenses online may save time in the ...oper eye care, new research shows. , Time saved ...ale clubs or optical chains were also less likely ...
... at any given time, almost 10 percent of the emerg...the United States miss work because of injuries an...examining how common these injuries are and tracki...ponders will suffer an injury or illness forcing t...
...ARRISBURG, Pa., Jan. 7 Nutrition has moved up on ...cent) consider the nutritional,content of foods th...did,two to three years ago, says a new survey from...en,s nutrition., However, the battle between nutr...
Other Medicine News:Health News:Low Vitamin D Linked to Heart Risk 2Health News:Low Vitamin D Linked to Heart Risk 3Health News:Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic 2Health News:Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic 3Health News:Cambrex Signs Agreement To Acquire ProSyntest AS 2Health News:Eye Care Lacking in Many Who Buy Contact Lenses Online 2Health News:Emergency responders at high risk to miss work because of injuries 2Health News:Emergency responders at high risk to miss work because of injuries 3Health News:Nutrition Moves Up on Mom's Purchasing Agenda 2Health News:Nutrition Moves Up on Mom's Purchasing Agenda 3
(Date:11/30/2009)...if., Nov. 30 StemCyte, Inc. conclu...eement with Academia Sinica, the National Laborato...Intellectual Property (IP) related to the treatmen...and IP was pioneered by a team led by Professor Jo...rofessor Lin is currently the exclusive collaborat...
(Date:11/30/2009)...LLS, Mich., Nov. 30 eHealthSource....ted exclusively to products approved for Flexible ...A) claims. The site is also the first to exclusiv...s, saving shoppers up to 75 percent on everyday he...wo common healthcare headaches - high costs and co...
(Date:11/30/2009)... Italy, November 30 Health Robotic... development plans and product specifications,for ...d Parenteral,Nutrition", a new key component of it...t Las Vegas, ASHP (Booth # 114). , "I loo...o the,TPNstation,s blueprints and to find out if T...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 1China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 2China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 1MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 4Obama Named the Most Powerful Person in Healthcare 55134 1Obama Named the Most Powerful Person in Healthcare 55134 2
...tes Presented at the,67th Annual Scientific Sessio..., June 25, 2007 /PRNewswire/ -- DiObex, Inc., a,pr...the development,of therapeutics to treat metabolic... line data of its phase 2a study of DIO-902, a,fir...e treatment of,type 2 diabetes. , Results of the t...
...- Neurogen,Corporation (Nasdaq: NRGN) today announ...g, Phase 2b clinical trials in chronic,insomnia pa...nt,NG2-73, an alpha-3 preferring GABA(A) partial ...h trial to determine the best,profile for rapidity...he night without residual sedation the next day., ...
Other Medicine Technology:DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 2DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8
...y EX.P.R.T. Release Technology essentially elimina...ent shortening,, Unique anatomically design...urcation,, 0.014 Rapid Exchange catheter wi...ic tip,, Radiopaque marker on catheter clea...
EZ Steer Bi-Directional Catheter
... whole blood assayed hematology control, offers co...ifferential available with the Coulter GENS, STKS,...-vial stability, 105-day closed-vial stability and...4.0ml pierceable cap vial is compatible with all c...
Pilot® Thoracolumbar Pedicle Screw System
Medicine Products: